These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 7538579

  • 1. The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits.
    Sprague JE, Nichols DE.
    J Pharmacol Exp Ther; 1995 May; 273(2):667-73. PubMed ID: 7538579
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of MAO-B protects against MDMA-induced neurotoxicity in the striatum.
    Sprague JE, Nichols DE.
    Psychopharmacology (Berl); 1995 Apr; 118(3):357-9. PubMed ID: 7542394
    [Abstract] [Full Text] [Related]

  • 3. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
    Hewton R, Salem A, Irvine RJ.
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093
    [Abstract] [Full Text] [Related]

  • 4. N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats.
    Yeh SY.
    Synapse; 1999 Mar 01; 31(3):169-77. PubMed ID: 10029234
    [Abstract] [Full Text] [Related]

  • 5. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
    Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB.
    J Pharmacol Exp Ther; 1987 Sep 01; 242(3):911-6. PubMed ID: 2443644
    [Abstract] [Full Text] [Related]

  • 6. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X, Baumann MH, Xu H, Rothman RB.
    Synapse; 2004 Sep 15; 53(4):240-8. PubMed ID: 15266556
    [Abstract] [Full Text] [Related]

  • 7. Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A.
    Alves E, Summavielle T, Alves CJ, Custódio JB, Fernandes E, de Lourdes Bastos M, Tavares MA, Carvalho F.
    Addict Biol; 2009 Apr 15; 14(2):185-93. PubMed ID: 19076925
    [Abstract] [Full Text] [Related]

  • 8. 2'-NH2-MPTP in Swiss Webster mice: evidence for long-term (6-month) depletions in cortical and hippocampal serotonin and norepinephrine, differential protection by selective uptake inhibitors or clorgyline and functional changes in central serotonin neurotransmission.
    Andrews AM, Murphy DL.
    J Pharmacol Exp Ther; 1993 Dec 15; 267(3):1432-9. PubMed ID: 8263805
    [Abstract] [Full Text] [Related]

  • 9. Acetyl-L-carnitine provides effective in vivo neuroprotection over 3,4-methylenedioximethamphetamine-induced mitochondrial neurotoxicity in the adolescent rat brain.
    Alves E, Binienda Z, Carvalho F, Alves CJ, Fernandes E, de Lourdes Bastos M, Tavares MA, Summavielle T.
    Neuroscience; 2009 Jan 23; 158(2):514-23. PubMed ID: 19015003
    [Abstract] [Full Text] [Related]

  • 10. A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy.
    Colado MI, O'Shea E, Granados R, Misra A, Murray TK, Green AR.
    Br J Pharmacol; 1997 Jun 23; 121(4):827-33. PubMed ID: 9208155
    [Abstract] [Full Text] [Related]

  • 11. Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide.
    Freezer A, Salem A, Irvine RJ.
    Brain Res; 2005 Apr 11; 1041(1):48-55. PubMed ID: 15804499
    [Abstract] [Full Text] [Related]

  • 12. Increased CRE-binding activity and tryptophan hydroxylase mRNA expression induced by 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") in the rat frontal cortex but not in the hippocampus.
    García-Osta A, Del Río J, Frechilla D.
    Brain Res Mol Brain Res; 2004 Jul 26; 126(2):181-7. PubMed ID: 15249142
    [Abstract] [Full Text] [Related]

  • 13. Differential effects of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on BDNF mRNA expression in rat frontal cortex and hippocampus.
    Martínez-Turrillas R, Moyano S, Del Río J, Frechilla D.
    Neurosci Lett; 2006 Jul 10; 402(1-2):126-30. PubMed ID: 16644117
    [Abstract] [Full Text] [Related]

  • 14. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
    Biezonski DK, Meyer JS.
    J Neurochem; 2010 Feb 10; 112(4):951-62. PubMed ID: 20002520
    [Abstract] [Full Text] [Related]

  • 15. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R, Kerans A, O'Neill B, Harkin A.
    Neuropharmacology; 2006 Jan 10; 50(1):69-80. PubMed ID: 16188283
    [Abstract] [Full Text] [Related]

  • 16. Protective effects of minocycline on 3,4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain.
    Zhang L, Shirayama Y, Shimizu E, Iyo M, Hashimoto K.
    Eur J Pharmacol; 2006 Aug 21; 544(1-3):1-9. PubMed ID: 16859675
    [Abstract] [Full Text] [Related]

  • 17. Studies on the mechanism of p-chloroamphetamine neurotoxicity.
    Sprague JE, Johnson MP, Schmidt CJ, Nichols DE.
    Biochem Pharmacol; 1996 Oct 25; 52(8):1271-7. PubMed ID: 8937435
    [Abstract] [Full Text] [Related]

  • 18. Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine.
    Stone DM, Johnson M, Hanson GR, Gibb JW.
    J Pharmacol Exp Ther; 1988 Oct 25; 247(1):79-87. PubMed ID: 2902215
    [Abstract] [Full Text] [Related]

  • 19. MDMA-induced neurotoxicity: long-term effects on 5-HT biosynthesis and the influence of ambient temperature.
    O'Shea E, Orio L, Escobedo I, Sanchez V, Camarero J, Green AR, Colado MI.
    Br J Pharmacol; 2006 Jul 25; 148(6):778-85. PubMed ID: 16770327
    [Abstract] [Full Text] [Related]

  • 20. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.
    Ricaurte GA, Martello AL, Katz JL, Martello MB.
    J Pharmacol Exp Ther; 1992 May 25; 261(2):616-22. PubMed ID: 1374470
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.